Ista makes three executive appointments
This article was originally published in Scrip
Executive Summary
Ista Pharmaceuticals, a California-based ophthalmic pharma company, has appointed Dr Doral Fredericks vice-president of medical affairs, Jane Pritchett Henderson vice-president of business development and Chris Dax vice-president of marketing. Dr Fredericks was most recently at Novartis Pharmaceuticals, where she held several roles, including regional scientific associate director, regional medical head and ad-interim vice-president of field medical affairs; Ms Henderson was previously chief financial officer and executive vice president of business development for Axerion Therapeutics; while Mr Dax most recently held senior positions at Elan, including vice-president of the US pain business and later senior vice-president of the autoimmune business.